Rare Disease, Facial Angiofibroma Associated with Tuberous Sclerosis Complex (TSC), is Focus of New Disease Education Website Launched by Nobelpharma America
FACE FORWARD, a new website focused on disease awareness, has launched with educational content on facial angiofibroma, an aspect of tuberous sclerosis complex (TSC).
- FACE FORWARD, a new website focused on disease awareness, has launched with educational content on facial angiofibroma, an aspect of tuberous sclerosis complex (TSC).
- FACE FORWARD also features background information about facial angiofibroma and TSC and a zip-code based tool that may help to locate certain treatment centers in the U.S.
- Stories from people with facial angiofibroma and their caregivers are also offered on the site, aspiring to provide insights into living with facial angiofibroma associated with TSC.
- BETHESDA, Md., Jan. 17, 2023 /PRNewswire/ -- Facial angiofibroma, an aspect of a rare genetic disease called tuberous sclerosis complex (TSC), is the focus of a new online resource, FACE FORWARD , launched by Nobelpharma America, LLC , a pharmaceutical and medical device company headquartered in Bethesda, Maryland.